# Allogene Therapeutics, Inc.: filings

ALLO · Nasdaq · CIK 1737287 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/allo.md) · [Financials](/companies/allo/financials.md) · [Filings](/companies/allo/filings.md) · [Insiders](/companies/allo/insiders.md)

## Reports and events: 137 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 243, 8-K 84, 144 41, 3 26, 10-Q 24, SCHEDULE 13G/A 18, SC 13G/A 16, DEFA14A 10, S-8 9, SC 13G 9, 10-K 8, CORRESP 8, DEF 14A 8, 424B5 7, UPLOAD 6, SCHEDULE 13G 5, ARS 4, SC 13D/A 4, 4/A 3, EFFECT 3, S-1/A 3, 8-K/A 2, CT ORDER 2, PRE 14A 2, S-3 2, S-3ASR 2, SC TO-I/A 2, 10-K/A 1, 144/A 1, 424B4 1, 5 1, 8-A12B 1, CERT 1, D 1, DRS 1, POS462B 1, POSASR 1, POS EX 1, S-1 1, S-1MEF 1, SC 13D 1, SCHEDULE 13D/A 1, SC TO-C 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-30 | 16:18 ET | [SCHEDULE 13D/A](/filings/0001999371-26-021654.md) | Ownership report, active investor, amended | 0001999371-26-021654 |
| 2026-09-02 | 08:35 ET | [8-K](/filings/0001193125-26-379423.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-379423 |
| 2026-08-12 | 16:17 ET | [10-Q](/filings/0001628280-26-056213.md) | Quarterly report, period 2026-06-30 | 0001628280-26-056213 |
| 2026-08-12 | 16:12 ET | [8-K](/filings/0001628280-26-056198.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-056198 |
| 2026-06-22 | 16:05 ET | [8-K](/filings/0001628280-26-044618.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001628280-26-044618 |
| 2026-05-28 | 17:06 ET | [8-K](/filings/0001193125-26-245484.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-245484 |
| 2026-05-13 | 16:05 ET | [10-Q](/filings/0001628280-26-034585.md) | Quarterly report, period 2026-03-31 | 0001628280-26-034585 |
| 2026-05-13 | 16:03 ET | [8-K](/filings/0001628280-26-034583.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-034583 |
| 2026-04-30 | 16:37 ET | [DEF 14A](/filings/0001628280-26-028948.md) | Proxy statement, period 2026-06-18 | 0001628280-26-028948 |
| 2026-04-15 | 16:35 ET | [8-K](/filings/0001193125-26-157140.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-157140 |
| 2026-04-13 | 16:09 ET | [8-K](/filings/0001193125-26-152866.md) | 8.01 Other events | 0001193125-26-152866 |
| 2026-04-13 | 07:45 ET | [8-K](/filings/0001193125-26-151999.md) | 8.01 Other events | 0001193125-26-151999 |
| 2026-03-12 | 16:11 ET | [10-K](/filings/0001628280-26-017242.md) | Annual report, period 2025-12-31 | 0001628280-26-017242 |
| 2026-03-12 | 16:07 ET | [8-K](/filings/0001628280-26-017230.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-017230 |
| 2025-11-06 | 16:30 ET | [10-Q](/filings/0001628280-25-050230.md) | Quarterly report, period 2025-09-30 | 0001628280-25-050230 |
| 2025-11-06 | 16:28 ET | [8-K](/filings/0001628280-25-050227.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-050227 |
| 2025-10-14 | 17:31 ET | [8-K](/filings/0001628280-25-044828.md) | 8.01 Other events | 0001628280-25-044828 |
| 2025-08-13 | 16:14 ET | [10-Q](/filings/0001737287-25-000088.md) | Quarterly report, period 2025-06-30 | 0001737287-25-000088 |
| 2025-08-13 | 16:08 ET | [8-K](/filings/0001737287-25-000087.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001737287-25-000087 |
| 2025-08-01 | 09:24 ET | [8-K](/filings/0001193125-25-171091.md) | 8.01 Other events | 0001193125-25-171091 |
| 2025-06-23 | 16:28 ET | [8-K](/filings/0001737287-25-000070.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001737287-25-000070 |
| 2025-05-13 | 16:07 ET | [10-Q](/filings/0001737287-25-000064.md) | Quarterly report, period 2025-03-31 | 0001737287-25-000064 |
| 2025-05-13 | 16:06 ET | [8-K](/filings/0001737287-25-000063.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001737287-25-000063 |
| 2025-04-30 | 18:11 ET | [DEF 14A](/filings/0001737287-25-000049.md) | Proxy statement, period 2025-06-18 | 0001737287-25-000049 |
| 2025-03-13 | 16:04 ET | [10-K](/filings/0001737287-25-000036.md) | Annual report, period 2024-12-31 | 0001737287-25-000036 |
| 2025-03-13 | 16:03 ET | [8-K](/filings/0001737287-25-000035.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001737287-25-000035 |
| 2025-02-25 | 16:18 ET | [8-K](/filings/0001193125-25-035162.md) | 1.01 Entry into a material agreement | 0001193125-25-035162 |
| 2025-01-29 | 08:35 ET | [8-K](/filings/0001193125-25-014985.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-014985 |
| 2024-11-13 | 16:29 ET | [8-K](/filings/0001737287-24-000075.md) | 8.01 Other events | 0001737287-24-000075 |
| 2024-11-07 | 16:13 ET | [10-Q](/filings/0001737287-24-000073.md) | Quarterly report, period 2024-09-30 | 0001737287-24-000073 |
| 2024-11-07 | 16:05 ET | [8-K](/filings/0001737287-24-000072.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001737287-24-000072 |
| 2024-10-07 | 16:28 ET | [8-K](/filings/0001737287-24-000062.md) | 5.05 Item not in the standard list; 9.01 Financial statements and exhibits | 0001737287-24-000062 |
| 2024-08-07 | 16:06 ET | [10-Q](/filings/0001737287-24-000056.md) | Quarterly report, period 2024-06-30 | 0001737287-24-000056 |
| 2024-08-07 | 16:04 ET | [8-K](/filings/0001737287-24-000055.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001737287-24-000055 |
| 2024-06-10 | 16:30 ET | [8-K](/filings/0001737287-24-000050.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001737287-24-000050 |
| 2024-05-31 | 16:31 ET | [8-K](/filings/0001737287-24-000046.md) | 1.01 Entry into a material agreement | 0001737287-24-000046 |
| 2024-05-14 | 16:40 ET | [8-K](/filings/0001193125-24-138316.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-138316 |
| 2024-05-13 | 16:03 ET | [10-Q](/filings/0001737287-24-000041.md) | Quarterly report, period 2024-03-31 | 0001737287-24-000041 |
| 2024-05-13 | 16:02 ET | [8-K](/filings/0001737287-24-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001737287-24-000040 |
| 2024-04-23 | 16:31 ET | [DEF 14A](/filings/0001737287-24-000032.md) | Proxy statement, period 2024-06-05 | 0001737287-24-000032 |
| 2024-03-14 | 16:55 ET | [10-K](/filings/0001737287-24-000021.md) | Annual report, period 2023-12-31 | 0001737287-24-000021 |
| 2024-03-14 | 16:10 ET | [8-K](/filings/0001737287-24-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001737287-24-000019 |
| 2024-03-14 | 16:00 ET | [10-K/A](/filings/0001737287-24-000018.md) | Annual report, amended, period 2022-12-31 | 0001737287-24-000018 |
| 2024-02-16 | 08:30 ET | [8-K](/filings/0001193125-24-038107.md) | 4.02 Non-reliance on financial statements | 0001193125-24-038107 |
| 2024-01-31 | 18:43 ET | [8-K](/filings/0001737287-24-000003.md) | 1.01 Entry into a material agreement | 0001737287-24-000003 |
| 2024-01-05 | 08:00 ET | [8-K](/filings/0001193125-24-002888.md) | 1.01 Entry into a material agreement; 2.05 Exit or disposal costs; 8.01 Other events | 0001193125-24-002888 |
| 2023-12-19 | 15:46 ET | [8-K](/filings/0001737287-23-000096.md) | 8.01 Other events | 0001737287-23-000096 |
| 2023-11-02 | 16:06 ET | [10-Q](/filings/0001737287-23-000091.md) | Quarterly report, period 2023-09-30 | 0001737287-23-000091 |
| 2023-11-02 | 16:03 ET | [8-K](/filings/0001737287-23-000089.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001737287-23-000089 |
| 2023-10-17 | 16:34 ET | [8-K/A](/filings/0001737287-23-000083.md) | 5.02 Departure or appointment of officers or directors | 0001737287-23-000083 |

Page 1 of 3. [Older](/companies/allo/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:28 ET. No prices; not investment advice.